Xtant Medical Holdings (XTNT) Share-based Compensation (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Share-based Compensation came in at $600000.0 in Q3 2025, down 45.45% year-on-year from $1.1 million in Q3 2024, and down 25.0% on a QoQ basis from $800000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Share-based Compensation (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Share-based Compensation data on file, last reported at $600000.0 in Q3 2025.
- On a quarterly basis, Share-based Compensation fell 45.45% year-over-year to $600000.0 in Q3 2025; TTM through Sep 2025 was $3.0 million, a 28.11% decrease from a year earlier, with the FY2024 full-year figure at $4.1 million, up 37.23% from the prior year.
- Share-based Compensation for Q3 2025 stood at $600000.0, down from $800000.0 in the prior quarter.
- Over the last five years, Share-based Compensation for XTNT reached as high as $3.6 million in Q3 2023 and fell as low as $456000.0 in Q1 2021.
- Historically, Share-based Compensation has averaged $996421.1 across 5 years, with a median of $758000.0 in 2025.
- Across the five-year window, Share-based Compensation jumped 461.62% in 2023 and slumped 69.44% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at $708000.0 in 2021, then retreated by 9.75% to $639000.0 in 2022, then soared by 46.79% to $938000.0 in 2023, then declined by 12.9% to $817000.0 in 2024, then fell by 26.56% to $600000.0 in 2025.
- Per Business Quant data, the three most recent Share-based Compensation figures were $600000.0 in Q3 2025, $800000.0 in Q2 2025, and $758000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 600,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 758,000.00 |
| Mar 31, 2025 | 758,000.00 |
| Dec 31, 2024 | 817,000.00 |
| Dec 31, 2024 | 817,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 938,000.00 |
| Dec 31, 2023 | 938,000.00 |
| Sep 30, 2023 | 3.60 Mn |
| Sep 30, 2023 | 3.60 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.50 Mn |